Dapagliflozin vs Rituximab

Dapagliflozin vs Rituximab: Overview

This comparison examines the pharmacological differences between Dapagliflozin and Rituximab.

Mechanism of Action

Dapagliflozin: Selective SGLT2 inhibitor reducing renal glucose and sodium reabsorption.

Rituximab: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.

Pharmacokinetics

Half-life: Dapagliflozin — 12.9 hours; Rituximab — 22 days.

Chemical Properties

Molecular Formula: Dapagliflozin — C21H25ClO6.

Molecular Weight: Dapagliflozin — 408.8730 g/mol.

Type: Dapagliflozin — Small molecule; Rituximab — Antibody.